Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting vimentin: a multifaceted approach to combatting cancer metastasis and drug resistance
Aliye Tabatabaee, Behjat Nafari, Armin Farhang, et al.
Cancer and Metastasis Reviews (2023) Vol. 43, Iss. 1, pp. 363-377
Closed Access | Times Cited: 19

Showing 19 citing articles:

Exploring vimentin's role in breast cancer via PICK1 alternative polyadenylation and the miR‐615‐3p‐PICK1 interaction
Xinyan Jia, Lujing Shao, Hong Quan, et al.
BioFactors (2025) Vol. 51, Iss. 1
Open Access
Predictive biomarkers of pancreatic cancer metastasis: A comprehensive review
Mengting Chen, Hongsen Liu, Yufei Xiao, et al.
Clinica Chimica Acta (2025), pp. 120176-120176
Closed Access
miR-124-mediated temozolomide sensitivity and DNA repair modulation in Glioblastoma Multiforme
Maryam Mafi Golchin, Ehsan Arefian, Zahra Fekrirad, et al.
Neuroscience (2025)
Closed Access
Cell surface vimentin: a natural human immune response target for immunotherapy
Mark C. Glassy
Frontiers in Molecular Medicine (2025) Vol. 5
Open Access
Epithelial-mesenchymal transition orchestrates tumor microenvironment: current perceptions and challenges
Yuqi Xie, Xuan Wang, Wenquan Wang, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Biomarkers for the detection of circulating tumor cells
Karol Gostomczyk, Magdalena Drozd, Mohammed Dheyaa Marsool Marsool, et al.
Experimental Cell Research (2025) Vol. 448, Iss. 1, pp. 114555-114555
Closed Access
Intersecting Pathways: The Role of Hybrid E/M Cells and Circulating Tumor Cells in Cancer Metastasis and Drug Resistance
Amirali Hariri, Mina Mirian, Arezoo Khosravi, et al.
Drug Resistance Updates (2024) Vol. 76, pp. 101119-101119
Closed Access | Times Cited: 3
Shake It Up Baby Now: The Changing Focus on TWIST1 and Epithelial to Mesenchymal Transition in Cancer and Other Diseases
Dureali Mirjat, Muhammad Kashif, Cai M. Roberts
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17539-17539
Open Access | Times Cited: 4
Crosstalk between cancer cell plasticity and immune microenvironment in cholangiocarcinoma
Mirko Minini, Allan Pavy, Bouchra Lekbaby, et al.
Hepatoma Research (2024)
Open Access | Times Cited: 1
LINC01559 promotes lung adenocarcinoma metastasis by disrupting the ubiquitination of vimentin
Hao Feng, Dengfei Xu, Chenyang Jiang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Targeting of S-phase kinase associated protein 2 stabilized tumor suppressors leading to apoptotic cell death in squamous skin cancer cells
Abdul Quaiyoom Khan, Maha Al-Tamimi, Rasheeda Anver, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 7, pp. 167286-167286
Closed Access | Times Cited: 1
Receptor-Based Strategies for Overcoming Resistance in Cancer Therapy
Naresh Sah, Abdul Althaf Shaik, Ganesh Acharya, et al.
Receptors (2024) Vol. 3, Iss. 4, pp. 425-443
Open Access | Times Cited: 1
Columbianadin ameliorates rheumatoid arthritis by attenuating synoviocyte hyperplasia through targeted vimentin to inhibit the VAV2/Rac-1 signaling pathway
Han Yu-li, Changqing Liu, Shujing Chen, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 1
Withaferin-A induced Vimentin S56 phosphorylation dissociates NEDD9 signaling loop to regress progressive metastatic melanoma into lung adenocarcinoma.
Ankith Sherapura, Bayram Kıran, G.S. Pavan Kumar, et al.
Chemico-Biological Interactions (2024), pp. 111319-111319
Closed Access | Times Cited: 1
Aptamers’ Potential to Fill Therapeutic and Diagnostic Gaps
Alfredo Berzal‐Herranz, Cristina Romero‐López
Pharmaceuticals (2024) Vol. 17, Iss. 1, pp. 105-105
Open Access
Exploring Vimentin's Role in Breast Cancer via PICK1 Alternative Polyadenylation and the miR-615-3p- PICK1 Interaction
Xinyan Jia, Lujing Shao, Hong Quan, et al.
Research Square (Research Square) (2024)
Open Access
High MICAL-L2 promotes cancer progression and drug resistance of renal clear cell carcinoma cell via stabilization of ACTN4 and following vimentin expression
Jun Du, Weizhen Zhao, Chenxiang Qi, et al.
Research Square (Research Square) (2024)
Open Access
High MICAL-L2 promotes cancer progression and drug resistance in renal clear cell carcinoma cells through stabilization of ACTN4 following vimentin expression
Weizhen Zhao, Chenxiang Qi, Yixin Mao, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 3, pp. 167628-167628
Closed Access
Experimental Validation and Multi-omics Analysis Identified ARPC1A as a Novel Oncogene and Potential Therapeutic Target in Glioblastoma
Jun Yang, Chengcheng Xue, Zesong He, et al.
Journal of Cancer (2024) Vol. 15, Iss. 12, pp. 3958-3974
Open Access
Page 1

Scroll to top